Leading Diabetes Management Platform
Glooko (glooko.com) earns a Brand Analyzer score of 76 out of 100, placing it in the Brand-Ready tier among Healthcare brands, SaaS brands. Among 2305 Healthcare brands analyzed, Glooko ranks in the 90th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 98/100, Digital Presence 82/100, Visual Identity 95/100, Messaging Clarity 95/100, Trust Foundation 56/100, AI Discoverability 82/100, Brand Authority 54/100.
Glooko is a healthcare SaaS company founded in 2011 and headquartered in Palo Alto, California. It connects patients, healthcare providers, and medical devices to simplify diabetes care. The platform integrates device data, streamlines clinical workflows, and delivers actionable insights across outpatient and inpatient settings. Glooko positions itself as a standard-setter for diabetes data security and management, and offers the only patient-specific insulin dosing system for glycemic management.
| Brand Name | Glooko |
|---|---|
| Domain | glooko.com |
| Industry | Healthcare, SaaS |
| Founded | 2011 |
| Headquarters | Palo Alto |
| Main Competitors | Dexcom (84/100), Medtronic Diabetes, Abbott FreeStyle LibreLink, Tidepool, One Drop, Livongo |
Moz Domain Authority 52/100 vs category average 29 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #63,421 on the Tranco list of most-visited sites - strong traffic reinforces the brand's prominence to AI models.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Glooko connects patients, providers, and devices to simplify diabetes care, streamline workflows, and deliver measurable health outcomes." (Meta description: 17 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 2 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on Instagram, LinkedIn, YouTube, GitHub; no detected presence on Facebook, X (Twitter) - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Glooko scores 47/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Glooko has a limited AI-visibility profile at 47/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (66/100) and its weakest is visibility (31/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #63,421 (Tranco) and a Moz Domain Authority of 52/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Glooko's main competitors include Dexcom (84/100), Medtronic Diabetes, Abbott FreeStyle LibreLink, Tidepool, One Drop. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Glooko official site
Glooko and Dexcom are competitors in Healthcare. Brand Analyzer scores Glooko at 76/100 and Dexcom at 84/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Glooko official site
Glooko offers a healthcare SaaS platform for diabetes care that includes seamless integration with diabetes-related medical devices, tools for streamlining clinical workflows, and actionable data insights for glycemic management. A key product feature is the patient-specific insulin dosing system for glycemic management, described as the only such system available. The platform serves both outpatient and inpatient care settings, addressing the full continuum of diabetes care.
Sources: Glooko official site
Glooko is a healthcare SaaS company founded in 2011 and based in Palo Alto, California. It operates a digital health platform focused on diabetes care, connecting patients, healthcare providers, and medical devices. Glooko positions itself as setting the standard for diabetes data security and management, serving both outpatient and inpatient care settings. It is notable for offering the only patient-specific insulin dosing system for glycemic management.
Sources: Glooko official site
Glooko connects patients, healthcare providers, and diabetes-related devices to simplify diabetes care. The platform integrates data from multiple devices seamlessly, streamlines clinical workflows for providers and clinicians, and delivers actionable insights to support glycemic management. It operates across the full continuum of diabetes care, spanning both outpatient and inpatient environments, and includes a patient-specific insulin dosing system designed to improve glycemic outcomes.
Sources: Glooko official site
Popular alternatives to Glooko include Dexcom (84/100), Medtronic Diabetes, Abbott FreeStyle LibreLink, Tidepool, One Drop. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Glooko official site
Glooko has limited AI-search visibility, scoring 47/100 on Brand Analyzer's AI visibility composite (visibility 31, trust 56, recommendation 66). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Glooko official site
Glooko was founded in 2011. Glooko operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Glooko is headquartered in Palo Alto. Glooko operates in the Healthcare category.
Sources: Wikidata
Glooko's platform is used by three primary groups: patients with diabetes who need to manage their condition, healthcare providers who oversee diabetes treatment and care coordination, and clinicians specifically focused on glycemic control. The platform is designed to serve both outpatient and inpatient care environments, making it applicable across a wide range of clinical contexts where diabetes management is required.
Sources: Glooko official site
Glooko is known for setting the standard for diabetes data security and management. It is specifically recognized for its seamless device integration capabilities, streamlined clinical workflows, and actionable data insights in diabetes care. Notably, Glooko is associated with offering the only patient-specific insulin dosing system for glycemic management, distinguishing it within the digital diabetes health space across both outpatient and inpatient care settings.
Sources: Glooko official site
Glooko scores 66/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Glooko official site
Glooko can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Glooko official site
Glooko is described as popular within the diabetes care space due to its ability to connect patients, providers, and devices in a unified platform. Its appeal stems from streamlined clinical workflows, seamless device integration, and actionable insights that support measurable health outcomes. The platform's coverage of the full continuum of diabetes care-both outpatient and inpatient-broadens its utility. Its patient-specific insulin dosing system also differentiates it from competitors.
Sources: Glooko official site
Ranked closest to Glooko: Plume Clinic (76/100), Foji (76/100), Hello Alpha (76/100), National Bleeding Disorders Foundation (76/100).
A step up - brands to learn from: Zipline (81/100), Zimmer Biomet (81/100).
Category leader: Dassault Systèmes (95/100).